Ali Gholamrezanezhad

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Michael Bräuer, Gregory A. Roth, Aleksandr Y. Aravkin et al. · The Lancet · 2024 · 2.1K citations · Full text

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Jaimie D Steinmetz, Katrin Seeher, Nicoline Schiess et al. · The Lancet Neurology · 2024 · 1.4K citations · Full text

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

Hazim Ababneh, Yohannes Habtegiorgis Abate, Cristiana Abbafati et al. · The Lancet · 2024 · 790 citations · Full text

Global Burden, Infectious Disease Epidemiology, Forecasting Analysis +13

Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome

Melina Hosseiny, Soheil Kooraki, Ali Gholamrezanezhad et al. · American Journal of Roentgenology · 2020 · 477 citations

In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis

Ali Gholamrezanezhad, Sahar Mirpour, Mohammad Bagheri et al. · Nuclear Medicine and Biology · 2011 · 261 citations

Regenerative Medicine, Vivo Tracking, Mesenchymal Stem Cells +15